You have 9 free searches left this month | for more free features.

Waldenstrom Macroglobulinemia

Showing 26 - 50 of 503

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 1, 2022

Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +6 more
  • New York, New York
    Weill Cornell Medicine
Dec 21, 2021

Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
Apr 1, 2022

MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MRD and clonal evolution
  • Milano, MI, Italy
  • +13 more
Nov 2, 2022

Clinical, Laboratory and Epidemiologic Characterization of

Recruiting
  • Waldenstrom Macroglobulinemia
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Waldenstrom Macroglobulinemia Trial in United States (Umbralisib)

    Completed
    • Waldenstrom Macroglobulinemia
    • Washington, District of Columbia
    • +3 more
    Oct 19, 2022

    B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

    Not yet recruiting
    • B-cell Malignancy
    • +7 more
    • (no location specified)
    Oct 26, 2022

    Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,

    Recruiting
    • Follicular B-cell Non-Hodgkin's Lymphoma
    • +7 more
    • MB-106
    • Orange, California
    • +3 more
    Nov 1, 2022

    Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

    Completed
    • Waldenström's Macroglobulinemia (WM)
    • Beijing, Beijing, China
    • +10 more
    Mar 7, 2022

    Patients Previously Treated WithMustang Bio CAR-T Cell

    Enrolling by invitation
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • +10 more
    • Prior MB-102 CAR-T cell investigational product.
    • Prior MB-106 CAR-T cell investigational product.
    • Duarte, California
    • +4 more
    Dec 8, 2022

    Waldenstrom Macroglobulinemia Trial in Austria, Germany, Greece (Carfilzomib + Ibrutinib, Ibrutinib)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Salzburg, Austria
    • +16 more
    Mar 11, 2022

    Waldenström Macroglobulinemia Trial in Vandoeuvre les Nancy (Blood or bone marrow samples)

    Completed
    • Waldenström Macroglobulinemia
    • Blood or bone marrow samples
    • Vandoeuvre les Nancy, France
      CHRU Nancy
    Aug 1, 2021

    Waldenstrom Macroglobulinemia Trial in New York (Epratuzumab (hLL2- anti-CD22 humanized antibody))

    Terminated
    • Waldenstrom Macroglobulinemia
    • Epratuzumab (hLL2- anti-CD22 humanized antibody)
    • New York, New York
    • +1 more
    Aug 12, 2021

    Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

    Recruiting
    • Mantle Cell Lymphoma
    • +9 more
    • L-Bcl-2 antisense oligonucleotide
    • Augusta, Georgia
    • +2 more
    Nov 18, 2022

    Waldenstrom Macroglobulinemia Trial in Germany, Greece (Ibrutinib / Bortezomib / Rituximab)

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • Ibrutinib / Bortezomib / Rituximab
    • Berlin, Germany
    • +14 more
    Mar 7, 2022

    Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +8 more
    • Iopofosine I 131 single dose
    • +2 more
    • Redlands, California
    • +42 more
    Dec 30, 2022

    Spanish Registry of Patients With IgM Monoclonal Gammopathies

    Recruiting
    • Waldenstrom Macroglobulinemia
      • Mieres, Asturias, Spain
      • +24 more
      Jul 5, 2022

      IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

      Recruiting
      • IgA Monoclonal Gammopathy
      • +8 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Oct 18, 2021

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • +7 more
      • Manchester, United Kingdom
      • +2 more
      Aug 11, 2022

      Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

      Withdrawn
      • Asymptomatic COVID-19 Infection Laboratory-Confirmed
      • +8 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Aug 2, 2022

      Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

      Active, not recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +6 more
      • Duarte, California
      • +8 more
      Jan 11, 2023

      Hyperviscosity Syndrome, Waldenstrom Macroglobulinemia Trial in Amiens (other, biological, procedure)

      Recruiting
      • Hyperviscosity Syndrome
      • Waldenstrom Macroglobulinemia
      • fundoscopic picture
      • +2 more
      • Amiens, France
        CHU Amiens
      May 19, 2021

      Waldenstrom's Disease, Waldenstrom Macroglobulinemia Trial in Amiens (bone marrow sample, blood sample)

      Recruiting
      • Waldenstrom's Disease
      • Waldenstrom Macroglobulinemia
      • bone marrow sample
      • blood sample
      • Amiens, France
        CHU Amiens
      May 17, 2021